Evaluation of Racial Disparities in Quality of Care for Patients With Gastrointestinal Tract Cancer Treated With Surgery
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.5664
Abstract: This cohort study examines whether racial disparities exist in treatment received and in survival among patients undergoing surgical intervention with curative intent for gastrointestinal tract cancer. read more here.
Keywords: evaluation racial; racial disparities; tract cancer; gastrointestinal tract ... See more keywords
Association Between Aspirin Use and Biliary Tract Cancer Survival
Sign Up to like & getrecommendations! Published in 2019 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2019.4328
Abstract: This database study analyzes the association between aspirin use and survival in patients with biliary tract cancer. read more here.
Keywords: aspirin use; association aspirin; tract cancer; biliary tract ... See more keywords
Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01.
Sign Up to like & getrecommendations! Published in 2025 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2025.4736
Abstract: This follow-up analysis of the phase 2 HERIZON-BTC-01 trial evaluates the efficacy, patient-reported outcomes, and safety profile of zanidatamab in patients with ERBB2-amplified biliary tract cancer with a HER2 immunohistochemistry score of 3+ or 2+… read more here.
Keywords: zanidatamab; tract cancer; herizon btc; biliary tract ... See more keywords
Main causes of death in advanced biliary tract cancer
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5794
Abstract: There are no previous reports on the main causes of death in biliary tract cancer (BTC) patients. This study aimed to evaluate the main causes of death and survival rates in patients with BTC. read more here.
Keywords: causes death; biliary tract; main causes; tract cancer ... See more keywords
A multi‐institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer
Sign Up to like & getrecommendations! Published in 2020 at "Cancer"
DOI: 10.1002/cncr.32964
Abstract: Regorafenib is an oral multikinase inhibitor targeting angiogenesis, oncogenesis, and cancer proliferation/metastasis. This study evaluated the efficacy of regorafenib in refractory biliary tract cancer (BTC) in a multi‐institutional phase 2 study. read more here.
Keywords: biliary tract; regorafenib refractory; tract cancer; multi institutional ... See more keywords
DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer
Sign Up to like & getrecommendations! Published in 2025 at "Cancer"
DOI: 10.1002/cncr.35726
Abstract: This study aims to explore the genetic characteristics of biliary tract cancer (BTC), with a particular focus on the impact of DNA damage response and repair (DDR) genes on clinical outcomes. read more here.
Keywords: dna damage; cancer; tract cancer; damage response ... See more keywords
Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer–Specific Mortality in a Large Nationwide Cohort
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.31879
Abstract: Biliary tract cancer (BTC) is rare and has limited treatment options. We aimed to examine aspirin use on cancer‐specific survival in various BTC subtypes, including gallbladder cancer, ampulla of Vater cancer, and cholangiocarcinoma. read more here.
Keywords: biliary tract; tract cancer; cancer specific; aspirin use ... See more keywords
Letter to the Editor: Proton pump inhibitors and Biliary Tract Cancer Risk: Causality or Reverse Causality?
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.32090
Abstract: We read with enormous interest the study by Kamal et al.1 For the past two decades, dispute on the carcinogenic effects of PPI has remained. In this retrospective study using nationwide registries, long-term use of… read more here.
Keywords: biliary tract; letter editor; tract cancer; causality ... See more keywords
Development and validation of a cancer cachexia risk score for digestive tract cancer patients before abdominal surgery
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Cachexia, Sarcopenia and Muscle"
DOI: 10.1002/jcsm.13207
Abstract: Cancer cachexia is prevalent in digestive tract cancer patients and has significant impacts on prognosis; it is vital to identify individuals who are at risk of cancer cachexia to allow for appropriate evaluation and treatment.… read more here.
Keywords: tract cancer; cancer cachexia; cancer patients; digestive tract ... See more keywords
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-017-3353-2
Abstract: PurposeBiliary tract cancer (BTC) is a heterogeneous group of diseases comprising intrahepatic and extrahepatic cholangiocarcinoma and gallbladder cancer. Although gemcitabine plus cisplatin (GEMCIS) was established as the standard first-line chemotherapy based on the ABC-02 trial,… read more here.
Keywords: tract cancer; prognostic factors; first line; analysis ... See more keywords
Genetic polymorphisms in cyclin H gene are associated with oxaliplatin-induced acute peripheral neuropathy in South Indian digestive tract cancer patients
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-018-3629-1
Abstract: PurposeDigestive tract cancer patients treated with oxaliplatin are often associated with the development of peripheral neuropathy. The aim of the present study is to identify the influence of single-nucleotide polymorphisms (SNPs) in genes involved in… read more here.
Keywords: tract cancer; peripheral neuropathy; cancer; cancer patients ... See more keywords